A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group

1997605 citationsJournal Article

Authors

P L Le Bars · Institute for Medical Research

Abstract

EGb was safe and appears capable of stabilizing and, in a substantial number of cases, improving the cognitive performance and the social functioning of demented patients for 6 months to 1 year. Although modest, the changes induced by EGb were objectively measured by the ADAS-Cog and were of sufficient magnitude to be recognized by the caregivers in the GERRI.

Topics & Keywords

Ginkgo biloba and Cashew Applications Neurological Disease Mechanisms and Treatments Dementia and Cognitive Impairment Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA

Volume 278, Issue 16, pp. 1327-1332

DOI: 10.1001/jama.278.16.1327

Field-Weighted Citation Impact: 55.78